DNA Repair Deficiency Regulates Immunity Response in Cancers: Molecular Mechanism and Approaches for Combining Immunotherapy
Defects in DNA repair pathways can lead to genomic instability in multiple tumor types, which contributes to tumor immunogenicity. Inhibition of DNA damage response (DDR) has been reported to increase tumor susceptibility to anticancer immunotherapy. However, the interplay between DDR and the immune...
Main Authors: | Yi Xu, Somaira Nowsheen, Min Deng |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/5/1619 |
Similar Items
-
DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma
by: Yunfei Chen, et al.
Published: (2021-07-01) -
Advances of DNA Damage Repair-Related Drugs and Combination With Immunotherapy in Tumor Treatment
by: Yumin Wang, et al.
Published: (2022-02-01) -
Role of DNA repair defects in predicting immunotherapy response
by: Jing Zhang, et al.
Published: (2020-06-01) -
DNA Damage Repair in Brain Tumor Immunotherapy
by: Shihong Zhao, et al.
Published: (2022-01-01) -
DNA Damage Response Evaluation Provides Novel Insights for Personalized Immunotherapy in Glioma
by: Mu Chen, et al.
Published: (2022-05-01)